Download DocumentationLabCorp Investor & Analyst Day Presentation

Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ... Read More >>

Recent News


LabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory Collaboration


LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest


Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development

Upcoming Events

There are currently no events scheduled.

LH (Common)
Change Stock is Down 2.23
Data as of 03/22/18 3:09 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet